Achieving high quality ligand chemistry in protein-ligand crystal structures for drug design

NATO Science for Peace and Security Series A: Chemistry and Biology

Volumn 38, Issue , 2015, Pages 165-181

  Smart, Oliver S ^a,b   Bricogne, Gérard ^a  

^a GLOBAL PHASING LTD   (United Kingdom)

^b SmartSci Limited St John s Innovation Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930668866     PISSN: 18746489     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-017-9719-1_13     Document Type: Article

References (47)

1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235–242
2. Smart OS (2014) Achieving high quality ligand chemistry in protein X-ray structures. Workshop prepared for the “Structural Basis of Pharmacology: Deeper Understanding of Drug Discovery through Crystallography”, Meeting Erice June 2014. http://grade.globalphasing.org/ tut/erice:workshop/
3. Leach AR, Gillet VJ (2003) An introduction to chemoinformatics. Kluwer Academic Publishers, Dordrecht/Boston
4. Nissink JWM, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49(4):457–471
5. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791
6. Sharff A, Keller P, Vonrhein C, Smart O, Womack T, Flensburg C, Paciorek W, Bricogne G (2014) Pipedream documentation, version 1.0.0. Global Phasing Ltd. http://www. globalphasing.com/buster/manual/pipedream/manual/index.html
7. Terwilliger TC, Bricogne G (2014) Continuous mutual improvement of macromolecular structure models in the PDB and of X-ray crystallographic software: the dual role of deposited experimental data. Acta Crystallogr D Biol Crystallogr 70(Pt 10):2533–2543
8. Buster-report. Global Phasing Ltd. https://www.globalphasing.com/buster/wiki/index.cgi? BusterReport
9. Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, Paciorek W, Roversi P, Sharff A, Smart OS, Vonrhein C, Womack TO (2014) BUSTER version 2.13.0. Global Phasing Ltd., Cambridge, UK
10. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macro-molecular crystallography. Acta Crystallogr Sect D: Biol Crystallogr 66:12–21
11. Bruno IJ, Cole JC, Kessler M, Luo J, Motherwell WDS, Purkis LH, Smith BR, Taylor R, Cooper RI, Harris SE, Orpen AG (2004) Retrieval of crystallographically-derived molecular geometry information. J Chem Inf Comput Sci 44(6):2133–2144
12. Allen FH (2002) The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr Sect B Struct Sci 58:380–388
13. Smart OS, Holstein J, Womack T (2014) Grade documentation. version 1.2.8. http://www. globalphasing.com/buster/manual/grade/manual/index.html
14. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr Sect D: Biol Crystallogr 66:486–501
15. Kleywegt GJ, Harris MR, Zou JY, Taylor TC, Wahlby A, Jones TA (2004) The Uppsala electron-density server. Acta Crystallogr Sect D: Biol Crystallogr 60:2240–2249
16. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D: Biol Crystallogr 67:355–367
17. Golubev AM, Nagem RAP, Neto JRB, Neustroev KN, Eneyskaya EV, Kulminskaya AA, Shabalin KA, Savel’ev AN, Polikarpov I (2004) Crystal structure of alpha-galactosidase from Trichoderma reesei and its complex with galactose: implications for catalytic mechanism. J Mol Biol 339(2):413–422
18. Rupp B (2010) Biomolecular crystallography: principles, practice, and application to structural biology. Garland Science, New York
19. Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, Womack T, Bricogne G (2011) Data processing and analysis with the autoPROC toolbox. Acta Crystallogr Sect D: Biol Crystallogr 67:293–302
20. Pozharski E, Weichenberger CX, Rupp B (2013) Techniques, tools and best practices for ligand electron-density analysis and results from their application to deposited crystal structures. Acta Crystallogr Sect D: Biol Crystallogr 69:150–167
21. Mir R, Singh N, Vikram G, Kumar RP, Sinha M, Bhushan A, Kaur P, Srinivasan A, Sharma S, Singh TP (2009) The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin. Biophys J 97(12):3178–3186. doi:10.1016/j.bpj.2009.09.030
22. Davis AM, St-Gallay SA, Kleywegt GJ (2008) Limitations and lessons in the use of X-ray structural information in drug design. Drug Discov Today 13(19–20):831–841. doi:10.1016/j.drudis.2008.06.006
23. Fyffe SA, Alphey MS, Buetow L, Smith TK, Ferguson MAJ, Sorensen MD, Bjorkling F, Hunter WN (2006) Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form. Mol Cell 21(1):1–2
24. Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, Ter-williger TC, Urzhumtsev A, Zwart PH, Adams PD (2012) Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr Sect D: Biol Crystallogr 68:352–367
25. Grade Web Server. Global Phasing Ltd. http://grade.globalphasing.org/
26. Smart OS, Womack TO, Flensburg C, Keller P, Paciorek W, Sharff A, Vonrhein C, Bricogne G (2012) Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr Sect D: Biol Crystallogr 68:368–380
27. Liebeschuetz J, Hennemann J, Olsson T, Groom CR (2012) The good, the bad and the twisted: a survey of ligand geometry in protein crystal structures. J Comput Aided Mol Des 26(2):169–183
28. Malinina L, Malakhova ML, Kanack AT, Lu M, Abagyan R, Brown RE, Patel DJ (2006) The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure. PLoS Biol 4(11):1996–2011
29. He X, Alian A, Stroud R, de Montellano PRO (2006) Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Med Chem 49(21):6308–6323
30. Wlodek S, Skillman AG, Nicholls A (2006) Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr Sect D: Biol Crystallogr 62:741–749
31. Kim HG, Tan L, Weisberg EL, Liu FY, Canning P, Choi HG, Ezell SA, Wu H, Zhao Z, Wang JH, Mandinova A, Griffin JD, Bullock AN, Liu QS, Lee SW, Gray NS (2013) Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem Biol 8(10):2145– 2150
32. Kim HG, Tan L, Weisberg EL, Liu FY, Canning P, Choi HG, Ezell S, Zhao Z, Wu H, Wang JH, Mandinova A, Bullock AN, Liu QS, Lee SW, Gray NS (2014) Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor (vol 8, pg 2145, 2013). ACS Chem Biol 9(3):840
33. Hars U, Horlacher R, Boos W, Welte W, Diederichs K (1998) Crystal structure of the effector-binding domain of the trehalose-repressor of Escherichia coli, a member of the LacI family, in its complexes with inducer trekalose-6-phosphate and noninducer trehalose. Protein Sci 7(12):2511–2521
34. Feng ZK, Chen L, Maddula H, Akcan O, Oughtred R, Berman HM, Westbrook J (2004) Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics 20(13):2153–2155
35. Dimitropoulos D, Ionides J, Henrick K (2006) Using MSDchem to search the PDB ligand dictionary. Current protocols in bioinformatics/editorial board, Andreas D Baxevanis [et al] Chapter 14:Unit14.13
36. Kabsch W (2010) XDS. Acta Crystallogr Sect D: Biol Crystallogr 66:125–132
37. Brunger AT (1992) Free R-value – a novel statistical quantity for assessing the accuracy of crystal-structures. Nature 355(6359):472–475
38. Scapin G, Patel SB, Lisnock J, Becker JW, LoGrasso PV (2003) The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. Chem Biol 10(8):705–712
39. Davis AM, Teague SJ, Kleywegt GJ (2003) Application and limitations of X-ray crystallo-graphic data in structure-based ligand and drug design. Angew Chem Int Ed 42(24):2718–2736
40. Kleywegt GJ (2007) Crystallographic refinement of ligand complexes. Acta Crystallogr Sect D: Biol Crystallogr 63:94–100
41. Joosten RP, Womack T, Vriend G, Bricogne G (2009) Re-refinement from deposited X-ray data can deliver improved models for most PDB entries. Acta Crystallogr Sect D: Biol Crystallogr 65:176–185
42. Malde AK, Mark AE (2011) Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes. J Comput Aided Mol Des 25(1):1–12
43. Warren GL, Do TD, Kelley BP, Nicholls A, Warren SD (2012) Essential considerations for using protein-ligand structures in drug discovery. Drug Discov Today 17(23–24):1270–1281
44. Reynolds CH (2014) Protein-ligand cocrystal structures: we can do better. ACS Med Chem Lett 5(7):727–729
45. Read RJ, Adams PD, Arendall WB, Brunger AT, Emsley P, Joosten RP, Kleywegt GJ, Krissinel EB, Lutteke T, Otwinowski Z, Perrakis A, Richardson JS, Sheffler WH, Smith JL, Tickle IJ, Vriend G, Zwart PH (2011) A new generation of crystallographic validation tools for the protein data bank. Structure 19(10):1395–1412
46. Dauter Z, Wlodawer A, Minor W, Jaskolski M, Rupp B (2014) Avoidable errors in deposited macromolecular structures: an impediment to efficient data mining. Int Union Crystallogr J 1(Pt 3):179–193
47. Joosten RP, Joosten K, Murshudov GN, Perrakis A (2012) PDB_REDO: constructive validation, more than just looking for errors. Acta Crystallogr Sect D: Biol Crystallogr 68:484–496